In addition, several reports indicate that in patients the expression of PlGF, or its specific inhibition, correlate with the metastatization process associated to different tumors as larynx carcinoma [40], squamous cell carcinoma [41], thyroid carcinoma [42], ovarian cancer [43] and non-small cell lung cancer [12]. Here, PGF is linked to ovarian carcinoma.